[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f36oti2k8guj61":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"approvalsBeforeLoe":23,"products":24,"patents":47,"exclusivities":48,"paragraphIv":49,"catalysts":51},"EFFEXOR XR","VENLAFAXINE HYDROCHLORIDE","UPJOHN","upjohn",[20],"020699","none",3,0,[25,34,38,43],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"020699-001","001","CAPSULE, EXTENDED RELEASE","ORAL","EQ 37.5MG BASE","1997-10-20","AB","RX",{"key":35,"applNo":20,"productNo":36,"dosageForm":28,"route":29,"strength":37,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"020699-002","002","EQ 75MG BASE",{"key":39,"applNo":20,"productNo":40,"dosageForm":28,"route":29,"strength":41,"approvalDate":31,"rld":4,"teCode":12,"type":42,"loe":12,"basis":21,"carveOutPossible":13},"020699-003","003","EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","DISCN",{"key":44,"applNo":20,"productNo":45,"dosageForm":28,"route":29,"strength":46,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"020699-004","004","EQ 150MG BASE",[],[],{"asOf":12,"firstFiled":12,"entries":50},[],[]]